The role of extracellular adenosine generation in the development of autoimmune diseases

F. Morandi, A. L. Horenstein, R. Rizzo, F. Malavasi

Research output: Contribution to journalReview article

Abstract

Adenosine (ADO) is an immunosuppressive molecule, which suppresses the immune responses by interacting with specific receptors expressed by immune effector cells. ADO is produced from ATP through the enzymatic activities of CD39 and CD73. Alternatively, ADO can be generated starting from NAD+, which is metabolized by the concerted action of CD38, CD203a/PC-1, and CD73. The role of ADO in immunity has been characterized in the last years in physiology and in pathological settings. This review examines a panel of reports focused on the functions of ADO in the context of human autoimmune/inflammatory diseases and the selected animal models. The final aim is to consider the role of adenosinergic ectoenzymes and ADO receptors as novel therapeutic targets for selected diseases.

Original languageEnglish
Article number7019398
JournalMediators of Inflammation
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

    Fingerprint

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this